Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Short communication: emerging transmitted HIV type 1 drug resistance mutations among patients prior to start of first-line antiretroviral therapy in middle and low prevalence sites in China.

Wang X, He C, Xing H, Liao L, Xu X, He J, Liu Y, Ling H, Liang S, Hsi JH, Ruan Y, Shao Y.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1637-9. doi: 10.1089/AID.2012.0164.

2.

The prevalence and determinants of drug-resistance-associated mutations in the HIV-1-infected MSM population of Henan Province in China.

Hou LJ, Wang HW, Duan SP, Zhuo Y, Zhou YC, Wu HJ, Shen BS.

Arch Virol. 2015 Aug;160(8):2051-61. doi: 10.1007/s00705-015-2481-4.

PMID:
26077516
3.

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China.

Xiaobai Z, Xi C, Tian H, Williams AB, Wang H, He J, Zhen J, Chiarella J, Blake LA, Turenchalk G, Kozal MJ.

PLoS One. 2014 Jun 4;9(6):e98740. doi: 10.1371/journal.pone.0098740.

4.

HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.

Moura ME, da Guarda Reis MN, Lima YA, Eulálio KD, Cardoso LP, Stefani MM.

J Med Virol. 2015 May;87(5):798-806. doi: 10.1002/jmv.24087.

PMID:
25649362
5.

Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).

Parikh UM, Kiepiela P, Ganesh S, Gomez K, Horn S, Eskay K, Kelly C, Mensch B, Gorbach P, Soto-Torres L, Ramjee G, Mellors JW; MTN-009 Protocol Team..

PLoS One. 2013 Apr 9;8(4):e59787. doi: 10.1371/journal.pone.0059787. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/8096d24f-06de-4e42-8834-b5d3e116253c. IPTc Taskforce [corrected to MTN-009 Protocol Team].

6.

Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.

Zhao B, Han X, Xu J, Hu Q, Chu Z, Zhang J, Lu L, Wang Z, Fu J, Chen X, Yan H, Zhuang M, Wang L, Sun A, Zhang CM, Shang H.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):250-5. doi: 10.1097/QAI.0000000000000467.

PMID:
25469530
7.

Low rate of transmitted drug resistance may indicate low access to antiretroviral treatment in Maranhão State, northeast Brazil.

Moura ME, Reis MN, Lima YA, Eulálio KD, Cardoso LP, Stefani MM.

AIDS Res Hum Retroviruses. 2015 Feb;31(2):250-4. doi: 10.1089/aid.2014.0261.

8.

HIV-1 drug resistance genotyping from antiretroviral therapy (ART) naïve and first-line treatment failures in Djiboutian patients.

Elmi Abar A, Jlizi A, Darar HY, Kacem MA, Slim A.

Diagn Pathol. 2012 Oct 8;7:138. doi: 10.1186/1746-1596-7-138.

9.

Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008-2011.

Dai L, Li N, Wei F, Li J, Liu Y, Xia W, Zhang T, Guo C, Wang W, Schwartz SA, Mahajan SD, Hsiao CB, Wu H.

Viral Immunol. 2014 Oct;27(8):392-7. doi: 10.1089/vim.2014.0025.

10.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
11.

The prevalence of transmitted drug resistance in newly diagnosed HIV-infected individuals in Croatia: the role of transmission clusters of men who have sex with men carrying the T215S surveillance drug resistance mutation.

Grgic I, Lepej SZ, Lunar MM, Poljak M, Vince A, Vrakela IB, Planinic A, Seme K, Begovac J.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):329-36. doi: 10.1089/AID.2012.0191.

12.

New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.

Zhao B, Han X, Dai D, Liu J, Ding H, Xu J, Chu Z, Bice T, Diao Y, Shang H.

AIDS Res Hum Retroviruses. 2011 Oct;27(10):1047-53. doi: 10.1089/AID.2010.0119.

PMID:
21417755
13.

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Puthanakit T, Jourdain G, Hongsiriwon S, Suntarattiwong P, Chokephaibulkit K, Sirisanthana V, Kosalaraksa P, Petdachai W, Hansudewechakul R, Siangphoe U, Suwanlerk T, Ananworanich J; HIV-NAT 086Study Team..

HIV Med. 2010 Oct 1;11(9):565-72. doi: 10.1111/j.1468-1293.2010.00828.x.

14.

High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.

Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):242-9. doi: 10.1089/aid.2011.0300.

PMID:
22860571
15.

HIV-1 reverse transcriptase drug-resistance mutations in chronically infected individuals receiving or naïve to HAART in Cameroon.

Burda ST, Viswanath R, Zhao J, Kinge T, Anyangwe C, Tinyami ET, Haldar B, Powell RL, Jarido V, Hewlett IK, Nyambi PN.

J Med Virol. 2010 Feb;82(2):187-96. doi: 10.1002/jmv.21677.

16.

Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.

Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D.

J Antimicrob Chemother. 2015;70(6):1881-4. doi: 10.1093/jac/dkv030.

17.

Prevalence of drug-resistant HIV type 1 at the time of initiation of antiretroviral therapy in Portland, Oregon.

MacVeigh MS, Kosmetatos MK, McDonald JE, Reeder JL, Parrish DA, Young TP.

AIDS Res Hum Retroviruses. 2013 Feb;29(2):337-42. doi: 10.1089/AID.2011.0386.

PMID:
22697610
18.

Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy.

Kakehasi FM, Tupinambás U, Cleto S, Aleixo A, Lin E, Melo VH, Aguiar RA, Pinto JA.

AIDS Res Hum Retroviruses. 2007 Dec;23(12):1515-20.

PMID:
18160009
19.

Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience.

Shet A, Berry L, Mohri H, Mehandru S, Chung C, Kim A, Jean-Pierre P, Hogan C, Simon V, Boden D, Markowitz M.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):439-46.

PMID:
16652051
20.

Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.

Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V; Red de Investigación en SIDA..

J Med Virol. 2005 Sep;77(1):23-8.

PMID:
16032728
Items per page

Supplemental Content

Support Center